Actively Recruiting
Open-Label Study of Cenobamate Safety, Efficacy, and Pharmacokinetics in Japanese Children Aged 2 to Under 18 with Partial-Onset Seizures
Led by Ono Pharmaceutical Co., Ltd. · Updated on 2026-10-09
20
Participants Needed
1
Research Sites
91 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, efficacy, and pharmacokinetics of cenobamate ONO-2017 in Japanese children aged 2 to under 18 years who have partial-onset focal seizures. This phase 3, open-label study focuses on pediatric patients with epilepsy whose seizures have not been fully controlled by other treatments. The study aims primarily to assess safety and tolerability, with secondary goals to understand how well the drug works and how it is processed in the body. Participants receive cenobamate in either tablet or syrup form, depending on their age and body weight. Tablets are given to children aged 12 to under 18 years, starting at 12.5 mg once daily and gradually increased up to a maximum of 400 mg per day, with adjustments based on symptoms and tolerability. Syrup form is administered to children aged 2 to under 18 years, dosed according to body weight to match the tablet dose. Doses are taken orally, typically in the morning with water, and treatment continues until the drug is approved and available on the market. During the study, participants are monitored closely for one year to track any adverse events or drug reactions. Researchers collect detailed seizure information from patient diaries and evaluate the drugs effects. Participants must have stable doses of 1 to 3 anti-seizure medications before joining. The study includes assessments of safety, seizure frequency, and drug levels to ensure careful observation of each childs response and well-being throughout the trial period.
CONDITIONS
Brief Title
A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
Research Team
N
North America Clinical Trial Support Desk
I
International Clinical Trial Support Desk
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here